We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Federal Judge Reiterates Expanded Safe-Harbor Protections for Generics
Federal Judge Reiterates Expanded Safe-Harbor Protections for Generics
July 30, 2013
A federal judge again dismissed Momenta Pharmaceuticals’ patent infringement claims against Teva and Amphastar, reiterating that the Hatch-Waxman Act’s safe-harbor provision extends to generic drugmakers’ use of patented inventions during both pre- and post-approval activities.